Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice

Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer

(2011) Qiushan He et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Targeting myeloid regulatory cells in cancer by chemotherapeutic agents

(2011) Hiam Naiditch et al.   IMMUNOLOGIC RESEARCH

Infection, immunoregulation, and cancer

(2011) Graham A. W. Rook et al.   IMMUNOLOGICAL REVIEWS

Immune parameters affecting the efficacy of chemotherapeutic regimens

(2011) Laurence Zitvogel et al.   Nature Reviews Clinical Oncology

Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells

(2011) Ramon Kaneno et al.   CELLULAR ONCOLOGY

Desirable cell death during anticancer chemotherapy

(2010) Clara Locher et al.   Annals of the New York Academy of Sciences

Myeloid-derived suppressor cell heterogeneity and subset definition

(2010) Elisa Peranzoni et al.   CURRENT OPINION IN IMMUNOLOGY

The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity

(2010) Je-In Youn et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The growing diversity and spectrum of action of myeloid-derived suppressor cells

(2010) Alberto Mantovani   EUROPEAN JOURNAL OF IMMUNOLOGY

IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function

(2010) Moshe Elkabets et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

T regulatory cells in cancer: recent advances and therapeutic potential

(2010) Eyad Elkord et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Changes in chromatin structure and methylation of the human interleukin-1β gene during monopoiesis

(2010) Inga Wessels et al.   IMMUNOLOGY

CTL Activation Using the Natural Low-Affinity Epitope 222-229 from Tyrosinase-Related Protein 1 Leads to Tumor Rejection

(2009) K. D. Pavelko et al.   CANCER RESEARCH

Generation of macrophages from peripheral blood monocytes in the rhesus monkey

(2009) Ann E. Rozner et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism

(2009) G. V. Shurin et al.   JOURNAL OF IMMUNOLOGY

Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer

(2009) S. Ostrand-Rosenberg et al.   JOURNAL OF IMMUNOLOGY

Melanoma Progression Despite Infiltration by In Vivo-primed TRP-2–specific T Cells

(2009) Vinod Singh et al.   JOURNAL OF IMMUNOTHERAPY

Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations

(2009) Ramon Kaneno et al.   Journal of Translational Medicine

Transforming growth-interacting factor (TGIF ) regulates proliferation and differentiation of human myeloid leukemia cells

(2009) Rizwan Hamid et al.   Molecular Oncology

Tricks tumors use to escape from immune control

(2009) Theresa L. Whiteside   ORAL ONCOLOGY

Adoptive transfer of pTRP2-specific CTLs expanding by bead-based artificial antigen-presenting cells mediates anti-melanoma response

(2008) Xiaoling Lu et al.   CANCER LETTERS

Melanoma-Specific Memory T Cells Are Functionally Active in Ret Transgenic Mice without Macroscopic Tumors

(2008) V. Umansky et al.   CANCER RESEARCH

Low-dose Chemotherapeutic Agents Regulate Small Rho GTPase Activity in Dendritic Cells

(2008) Galina V. Shurin et al.   JOURNAL OF IMMUNOTHERAPY